[HTML][HTML] Efficacy and safety of low-dose colchicine after myocardial infarction

…, D Rhainds, M Provencher, L Blondeau… - New England journal …, 2019 - Mass Medical Soc
Background Experimental and clinical evidence supports the role of inflammation in
atherosclerosis and its complications. Colchicine is an orally administered, potent antiinflammatory …

Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

…, H Gamra, GS Kiwan, L Blondeau… - European heart …, 2020 - academic.oup.com
Aims The COLchicine Cardiovascular Outcomes Trial (COLCOT) demonstrated the benefits
of targeting inflammation after myocardial infarction (MI). We aimed to determine whether …

Colchicine for secondary prevention of cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials

…, P Khairy, MP Dubé, L Blondeau… - Canadian Journal of …, 2021 - Elsevier
Background Reduction of inflammation with colchicine has emerged as a therapeutic option
for secondary prevention of cardiovascular disease (CVD) in patients with coronary artery …

Quality of life and functional capacity in patients with atrial fibrillation and congestive heart failure

…, M Talajic, F Lespérance, L Blondeau… - Journal of the American …, 2013 - jacc.org
Objectives : This study sought to assess the impact of rhythm- versus rate-control treatment
strategies and of underlying rhythm on quality of life and functional capacity in patients with …

Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis …

…, JD Adachi, YM Vigna, C Berger, L Blondeau… - Cmaj, 2001 - Can Med Assoc
Background: Positive and negative effects on bone mineral density (BMD) have been
described as a result of the premenopausal use of oral contraceptives (OCs); increased fracture …

Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

…, M Provencher, A Orfanos, L Blondeau… - … Journal-Quality of …, 2021 - academic.oup.com
Aims In the randomized, placebo-controlled Colchicine Cardiovascular Outcomes Trial (COLCOT)
of 4745 patients enrolled within 30 days after myocardial infarction (MI), low-dose …

Heart failure with anemia: novel findings on the roles of renal disease, interleukins, and specific left ventricular remodeling processes

…, JL Rouleau, M White, K Roy, L Blondeau… - Circulation: Heart …, 2014 - Am Heart Assoc
Background— Anemia is a highly prevalent and strong independent prognostic marker in
heart failure (HF), yet this association is not completely understood. Whether anemia is simply …

[HTML][HTML] Effects of P-selectin antagonist inclacumab in patients undergoing coronary artery bypass graft surgery: SELECT-CABG trial

…, RW Emery, S Robb, D Cournoyer, L Blondeau… - Journal of the American …, 2016 - jacc.org
Please note: This work was supported by a grant from the Société Française de Cardiologie.
Dr. Clementy has received funding for conference travel and educational symposia from …

Factors associated with failure of emergency department management in children with acute moderate or severe asthma: a prospective, multicentre, cohort study

…, MC Guertin, C Quach, L Blondeau… - The Lancet …, 2016 - thelancet.com
Background The management of paediatric asthma exacerbations is based on trials in
children of all ages. Recent studies from 2009 raised the possibility that preschoolers (younger …

Are operando measurements of rechargeable batteries always reliable? An example of beam effect with a mg battery

L Blondeau, S Surblé, E Foy, H Khodja… - Analytical …, 2022 - ACS Publications
Operando and in situ techniques are becoming mandatory to study Li-ion, post Li-ion, and
solid-state batteries. They are essential for monitoring the (electro)chemical and dynamic …